Medical Condition News

RSS

Researchers depict new statistical algorithm to identify genetic variations for common diseases

A group of researchers at The Scripps Research Institute and the Scripps Translational Science Institute has published a paper that reviews new strategies for identifying collections of rare genetic variations that reveal whether people are predisposed to developing common conditions like diabetes and cancer.

29 Oct 2010

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Pfizer Inc announced that the Japanese Ministry of Health, Labour and Welfare approved Lyrica (pregabalin) capsules for the treatment of peripheral neuropathic pain. This follows the recent approval in Japan of Lyrica for the treatment of postherpetic neuralgia on April 16, 2010. Lyrica is the first medication approved for peripheral neuropathic pain in Japan where it is co-promoted with Eisai Co., Ltd.

29 Oct 2010

Researchers find link between telomere length and colorectal cancer risk

For the first time, researchers have found a link between long telomeres and an increased risk for colorectal cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer Biology to Therapy, held here Oct. 27-30, 2010.

29 Oct 2010

Amira initiates AM152 Phase 1 clinical study for fibrotic diseases

Amira Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study with AM152, a novel LPA1 antagonist, in normal, healthy subjects.

29 Oct 2010

Latuda tablets receive FDA approval for treatment of adults with schizophrenia

The U.S. Food and Drug Administration today approved Latuda (lurasidone HCl) tablets for the treatment of adults with schizophrenia.

29 Oct 2010

Chillies for diabetes: Study

Researchers from Tasmania, Australia are recruiting volunteers in a study to explore if eating chillies can help control lifestyle-related diabetes. At present they need 35 people with type 2 diabetes or glucose intolerance.

28 Oct 2010

Common psychiatric drugs could slow dementia

Researchers say commonly used psychiatric drugs could be effective in slowing the progression of certain types of dementia. Dr John Kwok and colleagues from Neuroscience Research Australia have discovered a mutant gene that causes abnormal proteins build up in the brains of people with frontotemporal dementia, a disease that affects people in their 50s and 60s.

28 Oct 2010

Hemophiliacs, hepatitis and HIV: A magic cure gone wrong

The dark side of capitalism’s effect on the medical and pharmaceutical industries is chillingly exposed in Doctor Guilt? Benefits of Medical Treatment Compared with Hazards – A tradeoff (published by iUniverse), the provocative new nonfiction by Everett Winslow Lovrien, M.D.

28 Oct 2010

Pro-Pharmaceuticals ships first commercial order of DAVANAT to PROCAPS in Colombia

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced it has shipped its first commercial order of DAVANAT® to PROCAPS S.A., a large, international pharmaceutical company based in Barranquilla, Colombia. The $200,000 shipment of DAVANAT® will be used by PROCAPS to qualify its vial filling process.

28 Oct 2010

New oncology training program for registered nurses in Ghana

The National Cancer Coalition (NCC) and the Ghana based organization Breast Care International (BCI) are pleased to announce the successful implementation of their oncology training program for registered nurses in Ghana. The program was officially sponsored by the US headquartered Johnson & Johnson and focuses on early detection of breast and cervical cancers for improved survival outcomes.

28 Oct 2010

New computer program shows how brain's complex fiber tracks mature as we grow up

The brain's inner network becomes increasingly more efficient as humans mature. Now, for the first time without invasive measures, a joint study from the Ecole Polytechnique F-d-rale de Lausanne (EPFL) and the University of Lausanne (UNIL), in collaboration with Harvard Medical School, has verified these gains with a powerful new computer program. Reported in the PNAS early online edition last week, the soon-to-be-released software allows for individualized maps of vital brain connectivity that could aide in epilepsy and schizophrenia research.

28 Oct 2010

CCS presents new 2010 Atrial Fibrillation Guidelines

The Canadian Cardiovascular Society (CCS) presented its new 2010 Atrial Fibrillation Guidelines, the first update in six years, at the Canadian Cardiovascular Congress (CCC) in Montreal.

28 Oct 2010

Study examines heavy alcohol consumption

Problem drinkers in the general population may reduce the amount of alcohol they consume over a period of years but not to the level of the average adult, according to a new study in the November issue of the Journal of Studies on Alcohol and Drugs.

28 Oct 2010

NICE issues PTNS guidance for overactive bladder

Uroplasty, Inc. announced today that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) issued a guidance document titled "Percutaneous Posterior Tibial Nerve Stimulation for Overactive Bladder Syndrome," reinforcing the safety and effectiveness of PTNS for overactive bladder.

28 Oct 2010

New version of Addiction Severity Index performs well in psychometric terms

The new version of the Addiction Severity Index (ASI) gives health professionals the opportunity to design an integral and personalised plan of assistance for patients suffering disorders due to substance abuse.

28 Oct 2010

QLT expands QLT091001 Phase 1b LCA study to include patients with Retinitis Pigmentosa

QLT Inc. today announced expansion of the Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber Congenital Amaurosis (LCA) to include patients with Retinitis Pigmentosa (RP), a set of hereditary retinal diseases demonstrating clinical features similar to LCA.

28 Oct 2010

Octapharma initiates Human-cl rhFVIII clinical study for severe hemophilia A

Octapharma, one of the largest human protein products manufacturers in the world, today announced that patients diagnosed with severe hemophilia A have started treatment with the first recombinant Factor VIII derived from a human cell line (Human-cl rhFVIII). Researchers are investigating pharmacokinetics, efficacy, safety and immunogenicity of Human-cl rhFVIII for previously treated patients with severe hemophilia A.

28 Oct 2010

IsoRay completes Cs-131 brachytherapy seeds feasibility study for breast cancer treatment

IsoRay, Inc. announced, today, it has completed an initial feasibility study, which demonstrates the ability to use its patented Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) in accelerated partial breast irradiation (APBI) for breast cancer treatment.

28 Oct 2010

Researchers explore knowledge of palliative care oncologists with respect to genetic testing

If you were dying from cancer, would you consider genetic testing. A recent study conducted by researchers from Virginia Commonwealth University Massey Cancer Center showed that most terminally ill cancer patients who were eligible for genetic testing never received it despite that it could potentially save a relative's life.

28 Oct 2010

Pancreatic cancer develops and spreads more slowly than thought before

Pancreatic cancer develops and spreads much more slowly than scientists have thought, according to new research from Johns Hopkins investigators. The finding indicates that there is a potentially broad window for diagnosis and prevention of the disease.

28 Oct 2010